Seeking Alpha

GLYC
  GlycoMimetics - NASDAQ

9/20/2014, 4:10 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
GLYC vs. ETF Alternatives
Company Description
GlycoMimetics Inc is a clinical stage biotechnology company. The Company is engaged in discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role.
Sector: Healthcare
Industry: Biotechnology
Country: United States